Founder/Ceo
The Econophy Group LLC is a private equity independent sponsor focused on the biotech space. Prospective candidate technologies are developed through a global JV with a team of MDs, PhDs, and industry-related CROs. Considered a "hidden champion", its design and features can be characterized as becoming the "gold standard for the IVD industry, on a worldwide basis. Specialties include pulmonary diseases; TB for impacted countries and a derivative focused on the impact of Particulate Matter (PM), which is generated from Climate Change. The technology has the efficacy attributes to replace the US industry standard MAA diagnostic, which is limited to 50 microns of detection.